Clinical Trial Update: CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium

View source ↗

Summary

The CAUSE trial, studying patient-specific cellular characteristics in fibromuscular dysplasia and high-risk atherosclerotic endothelium, has completed. It was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Early-onset Coronary Artery Disease
• Fibromuscular Dysplasia

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Fibromuscular Dysplasia, Early Onset CAD | Status: COMPLETED